Newsletter | May 23, 2025

05.23.25 -- Squeezing CDMOs Dry? One Big Pharma VP Says Enough Is Enough

SPONSOR

We know how tough it can be to find the right CDMO, especially when capacity is tight and timelines are critical. That's why you’ll find our collection of recent Outsourced Pharma Capacity Update presentations so valuable. Our April Partners Week Update details the latest capabilities and available capacity from 40 leading CDMOs – and you can experience it all from the convenience of your screen. View the on-demand sessions for the modalities that fit your needs.

INDUSTRY INSIGHTS

Friendshoring: A Strategic Shift In Pharma Supply Chains

To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

Ensuring Tablet Logo Legibility: A Critical Step In Preventing Medication Errors

Tablet debossing aids medication identification and must meet FDA standards. Font, scale, color, shadow, and stroke details are key for optimal legibility and safety.

Achieving Desired Particle Size And Yield Through Efficient Micronization

In this presentation, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.

FEATURED EDITORIAL

Squeezing CDMOs Dry? One Big Pharma VP Says Enough Is Enough

A Big Pharma pro is battling in the outsourcing ring—and she’s in the CDMO’s corner. Lynn Cinelli, VP of Global Biologics Supply Chain at Bristol Myers Squibb, is taking on sponsors blind to inefficiencies that burden their external partners.

Addressing Human 'Error' In Pharma Manufacturing

Why is it that managers at pharma manufacturing sites continue to be frustrated by what could be labeled as “avoidable” human errors, and what can companies do about it? Let's investigate.

INDUSTRY INSIGHTS CONTINUED

Empowering API Manufacturing: Perspectives From A CDMO

Watch as we delve into key implications for CDMOs, with strategies to boost API manufacturing, enhance global competitiveness, and strengthen European healthcare resilience.

Expanding The OSD Toolbox

This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

Unified Capabilities To Support Your Product Development Journey

Through a breadth of facilities, resources, and experience, gain insight into an FCMS that can serve customers’ needs from coast to coast to ensure supply chain efficiency and safety.

SOLUTIONS

Cambrex Scientist Spotlight: Elena Bejan

Holding a Ph.D. in organic chemistry from Paris-Sud University and an MBA from the Rotman School of Management, Bejan leads R&D efforts at Cambrex with a focus on scientific innovation.

Frozen Packaging Solutions

Achieve higher operational efficiency and lower quality and safety risks by utilizing this partner's scalable packaging services for logistics support.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: